Article |

An Epidemiologic Study of Gilles de la Tourette's Syndrome in Israel

Alan Apter, MD; David L. Pauls, PhD; Avi Bleich, MD; Ada H. Zohar, PhD; Shmuel Kron, MD; Gidi Ratzoni, MD; Anat Dycian, MA; Moshe Kotler, MD; Avi Weizman, MD; Natan Gadot, MD; Donald J. Cohen, MD
Arch Gen Psychiatry. 1993;50(9):734-738. doi:10.1001/archpsyc.1993.01820210068008.
Text Size: A A A
Published online

Objectives:  The goal of this study was to estimate the lifetime prevalence of Gilles de la Tourette's syndrome (GTS) in adolescents aged 16 to 17 years.

Design:  Population-based epidemiologic study.

Subjects:  Eighteen thousand three hundred sixty-four males and 9673 females aged 16 to 17 years screened for induction into the Israel Defense Force.

Results:  Of the 28 037 individuals screened, 12 met diagnostic criteria for GTS. The point prevalence in this population was 4.3±1.2 (mean±SE) per 10 000. The 95% confidence interval for this estimate is 1.9 to 6.7 per 10 000. The point prevalence was 4.9 ±1.6 per 10 000 for males (95% confidence interval, 1.8 per 10 000) and 3.1 ±1.8 per 10 000 for females (95% confidence interval, 0 to 6.6 per 10 000). The rate of obsessive-compulsive disorder (OCD) was significantly elevated among the subjects with GTS (41.7%) compared with the population point prevalence of OCD (3.4) in those without GTS. In contrast, the rate of attention deficit hyperactivity disorder was only 8.3% compared with the population point prevalence of 3.9% in those individuals without GTS.

Conclusions:  The prevalence estimates from this population-based study are in agreement with previous results based on surveys of younger children. The sex ratio observed in this study is not as large as reported in Previous studies and remains to be explored in other studies of adolescents and adults.


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.